These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26085138)

  • 1. Discovery of another anti-HIV protein in the search for the CD8+ cell anti-HIV Factor.
    Levy JA
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):7888-9. PubMed ID: 26085138
    [No Abstract]   [Full Text] [Related]  

  • 2. TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability.
    Sperandio S; Barat C; Cabrita MA; Gargaun A; Berezovski MV; Tremblay MJ; de Belle I
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):E3392-401. PubMed ID: 26056259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion of human immunodeficiency virus type 1 (HIV-1) with human cells as measured by membrane fluorescence dequenching (DQ) method; roles of HIV-1-cell fusion in AIDS pathogenesis.
    Volsky DJ
    Prog Clin Biol Res; 1990; 343():179-98. PubMed ID: 2198580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GADD45 proteins inhibit HIV-1 replication through specific suppression of HIV-1 transcription.
    Liang Z; Liu R; Zhang H; Zhang S; Hu X; Tan J; Liang C; Qiao W
    Virology; 2016 Jun; 493():1-11. PubMed ID: 26994425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraspanin functions during HIV-1 and influenza virus replication.
    Thali M
    Biochem Soc Trans; 2011 Apr; 39(2):529-31. PubMed ID: 21428933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New targets for inhibitors of HIV-1 replication.
    Moore JP; Stevenson M
    Nat Rev Mol Cell Biol; 2000 Oct; 1(1):40-9. PubMed ID: 11413488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of membrane lipid and fluidity modifications on HIV-1 infectibility of primate lymphocytes in vitro.
    Zimmer JP; Lehr HA; Hübner C; Lindner SG; Ramsperger R; Claussen M; Kohlschütter A; Schmitz H
    Biosci Rep; 1990 Jun; 10(3):263-70. PubMed ID: 2224064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication.
    Cicala C; Arthos J; Selig SM; Dennis G; Hosack DA; Van Ryk D; Spangler ML; Steenbeke TD; Khazanie P; Gupta N; Yang J; Daucher M; Lempicki RA; Fauci AS
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9380-5. PubMed ID: 12089333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of IL-16 in HIV replication.
    Mackewicz CE; Levy JA; Cruikshank WW; Kornfeld H; Center DM
    Nature; 1996 Oct; 383(6600):488-9. PubMed ID: 8849720
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research advances on fusion peptide and mechanisms about virus penetration into membrane].
    Wu M; Nie SQ
    Sheng Li Ke Xue Jin Zhan; 1998 Jul; 29(3):221-5. PubMed ID: 12501639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV provides ample PAMPs for innate immune sensing.
    Lee B
    Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19183-4. PubMed ID: 24225850
    [No Abstract]   [Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target.
    Cammack N
    Antivir Chem Chemother; 1999 Mar; 10(2):53-62. PubMed ID: 10335399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
    Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
    J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV entry inhibition by the envelope 2 glycoprotein of GB virus C.
    Jung S; Eichenmüller M; Donhauser N; Neipel F; Engel AM; Hess G; Fleckenstein B; Reil H
    AIDS; 2007 Mar; 21(5):645-7. PubMed ID: 17314528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion.
    Mkrtchyan SR; Markosyan RM; Eadon MT; Moore JP; Melikyan GB; Cohen FS
    J Virol; 2005 Sep; 79(17):11161-9. PubMed ID: 16103167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
    Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G
    J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D; Notkins AL; Zhou P
    J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapies based on mechanisms of HIV-1 cell entry.
    Kilby JM; Eron JJ
    N Engl J Med; 2003 May; 348(22):2228-38. PubMed ID: 12773651
    [No Abstract]   [Full Text] [Related]  

  • 19. The miRNA miR-34a enhances HIV-1 replication by targeting PNUTS/PPP1R10, which negatively regulates HIV-1 transcriptional complex formation.
    Kapoor R; Arora S; Ponia SS; Kumar B; Maddika S; Banerjea AC
    Biochem J; 2015 Sep; 470(3):293-302. PubMed ID: 26188041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 and the host cell: an intimate association.
    Freed EO
    Trends Microbiol; 2004 Apr; 12(4):170-7. PubMed ID: 15051067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.